{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:41:17Z","timestamp":1791153677795,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2002,5,1]],"date-time":"2002-05-01T00:00:00Z","timestamp":1020211200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2002,5]]},"DOI":"10.1007\/s11926-002-0073-2","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T12:58:35Z","timestamp":1180789115000},"page":"252-256","source":"Crossref","is-referenced-by-count":177,"title":["Update on colchicine and its mechanism of action"],"prefix":"10.1007","volume":"4","author":[{"given":"Yair","family":"Molad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"73_CR1","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.13.3.190","volume":"13","author":"EF Hartung","year":"1954","unstructured":"Hartung EF: History of the use of colchicum and related medicaments in gout. Ann Rheum Dis 1954, 13:190\u2013200.","journal-title":"Ann Rheum Dis"},{"key":"73_CR2","first-page":"69","volume":"14","author":"PJ Pelletier","year":"1820","unstructured":"Pelletier PJ, Caventou JB: Examen clinique de plusiers vegetaux de la famille des colchicees et du principe actif qu\u2019ils enferment. Ann Chim Phys 1820, 14:69.","journal-title":"Ann Chim Phys"},{"key":"73_CR3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0002-9343(70)90043-4","volume":"48","author":"SL Wallace","year":"1970","unstructured":"Wallace SL, Omokoku B, Ertel NH: Colchicine plasma levels: implications as to pharmacology and mechanism of action. Am J Med 1970, 48:443\u2013448.","journal-title":"Am J Med"},{"key":"73_CR4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0026-0495(73)90247-3","volume":"22","author":"SL Wallace","year":"1973","unstructured":"Wallace SL, Ertel NH: Plasma levels of colchicine after oral administration of a single dose. Metabolism 1973, 22:749\u2013753.","journal-title":"Metabolism"},{"key":"73_CR5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF00194404","volume":"46","author":"M Rochdi","year":"1994","unstructured":"Rochdi M, Sabouraud A, Girre C, et al.: Pharmacokinetics and absolute bioavailability of colchicine after i.v. and oral administration in healthy human volunteers and elderly subjects. Eur J Clin Pharmacol 1994, 46:351\u2013354.","journal-title":"Eur J Clin Pharmacol"},{"key":"73_CR6","first-page":"429","volume":"32","author":"A Sabouraud","year":"1994","unstructured":"Sabouraud A, Chappey O, Dupin T, Scherrmann JM: Binding of colchicine and thiocolchicoside to human serum proteins and blood cells. Int J Clin Pharmacol Ther 1994, 32:429\u2013432.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"73_CR7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/j.1552-4604.1996.tb04753.x","volume":"36","author":"GM Ferron","year":"1996","unstructured":"Ferron GM, Rochdi M, Jusko WJ, Scherrmann JM: Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses. J Clin Pharmacol 1996, 36:874\u2013883.","journal-title":"J Clin Pharmacol"},{"key":"73_CR8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/clpt.1993.161","volume":"54","author":"ON Chappey","year":"1993","unstructured":"Chappey ON, Niel E, Wautier JL, et al.: Colchicine deposition in human leukocytes after single and multiple oral administration. Clin Pharmacol Ther 1993, 54:360\u2013367.","journal-title":"Clin Pharmacol Ther"},{"key":"73_CR9","first-page":"710","volume":"21","author":"E Ben-Chetrit","year":"1994","unstructured":"Ben-Chetrit E, Scherrmann JM, Zylber-Katz E, Levy M: Colchicine disposition in patients with familial Mediterranean fever with renal impairment. J Rheumatol 1994, 21:710\u2013713.","journal-title":"J Rheumatol"},{"key":"73_CR10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0002-9343(61)90052-3","volume":"30","author":"SL Wallace","year":"1961","unstructured":"Wallace SL: Colchicine: clinical pharmacology in acute gouty arthritis. Am J Med 1961, 30:439.","journal-title":"Am J Med"},{"key":"73_CR11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1126\/science.156.3774.521","volume":"156","author":"SE Malawista","year":"1967","unstructured":"Malawista SE, Bensch KG: Human polymorphonuclear leukocytes: demonstration of microtubules and effect of colchicine. Science 1967, 156:521\u2013522.","journal-title":"Science"},{"key":"73_CR12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/art.1780110210","volume":"11","author":"SE Malawista","year":"1968","unstructured":"Malawista SE: Colchicine: a common mechanism for its antiinflammatory and anti-mitotic effects. Arthritis Rheum 1968, 11:191\u2013197.","journal-title":"Arthritis Rheum"},{"key":"73_CR13","first-page":"601","volume":"7","author":"M Bessis","year":"1967","unstructured":"Bessis M, Breton-Gorius J: Rapports entre noyau et centrioles dans les granulocytes \u00e9talal\u00e9s. Rule des microtubules. Nouvelle Revue Francaise d\u2019H\u00e9matologie 1967, 7:601\u2013620.","journal-title":"Nouvelle Revue Francaise d\u2019H\u00e9matologie"},{"key":"73_CR14","doi-asserted-by":"crossref","first-page":"13560","DOI":"10.1021\/bi00212a023","volume":"32","author":"DL Sackett","year":"1993","unstructured":"Sackett DL, Varma JK: Molecular mechanism of colchicine action: induced local unfolding of b-tubulin. Biochemistry 1993, 32:13560\u201313565.","journal-title":"Biochemistry"},{"key":"73_CR15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/bj3230189","volume":"323","author":"A Candelaere Van de","year":"1997","unstructured":"Van de Candelaere A, Martin SR, Engelborghs Y: Response of microtubules to the addition of colchicine and tubulincolchicine: evaluation of models for the interaction of drugs with microtubules. Biochem J 1997, 323:189\u2013196.","journal-title":"Biochem J"},{"key":"73_CR16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.1780180729","volume":"18","author":"SE Malawista","year":"1975","unstructured":"Malawista SE: The action of colchicine in acute gouty arthritis. Arthritis Rheum 1975, 18:835\u2013846.","journal-title":"Arthritis Rheum"},{"key":"73_CR17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11926-001-0049-7","volume":"3","author":"CL Landis","year":"2001","unstructured":"Landis CL, Haskard DO: Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep 2001, 3:36\u201341. This paper summarizes the latest studies on the importance of various inflammatory cells and cytokines in the initiation, amplification, and spontaneous cessation of gout attack.","journal-title":"Curr Rheumatol Rep"},{"key":"73_CR18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI115142","volume":"87","author":"FS Giovine Di","year":"1991","unstructured":"Di Giovine FS, Malawista SE, Thornton E, Duff GW: Urate crystals stimulate production of tumor necrosis factor alfa from human blood monocytes and synovial cells: cytokine mRNA and protein kinetics, and cellular ditribution. J Clin Invest 1991, 87:1375\u20131381.","journal-title":"J Clin Invest"},{"key":"73_CR19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF01993232","volume":"34","author":"CJ Roberge","year":"1991","unstructured":"Roberge CJ, Grassi J, de Medicis R, et al.: Crystal-neutrophil interactions lead to interleukin-1 synthesis. Agents Actions 1991, 34:38\u201341.","journal-title":"Agents Actions"},{"key":"73_CR20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0171-2985(96)80027-1","volume":"195","author":"Z Li","year":"1996","unstructured":"Li Z, Davis GS, Mohr C, et al.: Inhibition of LPS-induced tumor necrosis factor-a production by colchicine and other microtubules disrupting drugs. Immunobiology 1996, 195:624\u2013639.","journal-title":"Immunobiology"},{"key":"73_CR21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1084\/jem.171.3.715","volume":"171","author":"AH Ding","year":"1990","unstructured":"Ding AH, Porteu F, Sanchez E, Nathan CF: Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by mictotubule depolarizing agents. J Exp Med 1990, 171:715\u2013727.","journal-title":"J Exp Med"},{"key":"73_CR22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0090-6980(84)90085-6","volume":"27","author":"CN Serhen","year":"1984","unstructured":"Serhen CN, Lundberg U, Weissmann G, Samuelsson B: Formation of leukotrienes and hydroxy acids from human neutrophils and platelets exposed to monosodium urate. Prostaglandins 1984, 27:503\u2013581.","journal-title":"Prostaglandins"},{"key":"73_CR23","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4049\/jimmunol.136.3.1027","volume":"136","author":"J Reibman","year":"1986","unstructured":"Reibman J, Haines KA, Rich AM, et al.: Colchicine inhibits ionophor-induced formation of leukotriene B4 by human neutrophils: the role of microtubules. J Immunol 1986, 136:1027\u20131032.","journal-title":"J Immunol"},{"key":"73_CR24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2125.1980.tb01759.x","volume":"10","author":"M Ehrenfeld","year":"1980","unstructured":"Ehrenfeld M, Levy M, Bar Eli M, et al.: Effect of colchicine on polymorphonuclear leukocyte chemotaxis in human volunteers. Br J Clin Pharmacol 1980, 10:297\u2013300.","journal-title":"Br J Clin Pharmacol"},{"key":"73_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02022983","volume":"28","author":"P Hambleton","year":"1989","unstructured":"Hambleton P, Miller P: Pharmacological investigation of acute cellular accumulation in immunological air pouch inflammation. Agents Actions 1989, 28:73\u201377.","journal-title":"Agents Actions"},{"key":"73_CR26","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/1529-0131(200005)43:5<1145::AID-ANR25>3.0.CO;2-T","volume":"43","author":"RU Liu","year":"2000","unstructured":"Liu RU, O\u2019Connell M, Johnson K, et al.: Extracellular signalregulated kinase 1\/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor _B transcription factors play central roles in interleukin-8 expression stimulated by monosodium urate monohydrate and calcium pyrophosphate crystals in monocytic cells. Arthritis Rheum 2000, 43:1145\u20131155. This study explores the the intracellular signaling pathways involved in crystal-induced mitogen-activated protein kinase signal transduction and interleukin-8 transcriptional activation in human monocytic cells.","journal-title":"Arthritis Rheum"},{"key":"73_CR27","first-page":"158","volume":"164","author":"E Gillespie","year":"1968","unstructured":"Gillespie E, Levine RJ, Malawista SE: Histamine release from rat peritoneal mast cells: inhibition by colchicines and potentiation by deuterium oxide. J Pharmacol Exp Ther 1968, 164:158\u2013165.","journal-title":"J Pharmacol Exp Ther"},{"key":"73_CR28","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1182\/blood.V91.5.1769","volume":"91","author":"M Pouliot","year":"1998","unstructured":"Pouliot M, James MJ, McColl SR, et al.: Monosodium urate microcrystals induce cyclooxygenase-2 in human monocytes. Blood 1998, 91:1769\u20131776. This paper describes the effect of monosodium urate crystals on monocyte cyclooxygenase-2 and prostanoid production, which is inhibited by colchicine.","journal-title":"Blood"},{"key":"73_CR29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1136\/ard.40.6.605","volume":"40","author":"JN Fordham","year":"1981","unstructured":"Fordham JN, Kirwan J, Cason J, Currey HLF: Prolonged reduction in polymorphonuclear adhesion following oral colchicine. Ann Rheum Dis 1981, 40:605\u2013608.","journal-title":"Ann Rheum Dis"},{"key":"73_CR30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00917514","volume":"16","author":"H Asako","year":"1992","unstructured":"Asako H, Kubes P, Baethge BA, et al.: Colchicine and methotrexate reduce leukocyte adherence and emigration in rat mesenteric venules. Inflammation 1992, 16:45\u201356.","journal-title":"Inflammation"},{"key":"73_CR31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/art.1780360204","volume":"36","author":"BN Cronstein","year":"1993","unstructured":"Cronstein BN, Weissmann G: The adhesion molecules of inflammation. Arthritis Rheum 1993, 36:147\u2013157.","journal-title":"Arthritis Rheum"},{"key":"73_CR32","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","volume":"96","author":"BN Cronstein","year":"1995","unstructured":"Cronstein BN, Molad Y, Reibman J, et al.: Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest 1995, 96:994\u20131002.","journal-title":"J Clin Invest"},{"key":"73_CR33","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1476-5381.1996.tb15353.x","volume":"117","author":"M Paya","year":"1996","unstructured":"Paya M, Terencio MC, Ferrandiz ML, Alcaraz MJ: Involvement of secretory phospholipase A2 activity in the zymosan air pouch model of inflammation. Br J Pharmacol 1996, 117:1773\u20131779.","journal-title":"Br J Pharmacol"},{"key":"73_CR34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1083\/jcb.58.1.27","volume":"58","author":"RB Zurier","year":"1973","unstructured":"Zurier RB, Hoffstein S, Weissmann G: Mechanisms of lysosomal enzyme release from human leukocytes: I, effect of cyclic nucleotides and colchicine. J Cell Biol 1973, 58:27\u201341.","journal-title":"J Cell Biol"},{"key":"73_CR35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/art.1780160608","volume":"16","author":"DG Wright","year":"1973","unstructured":"Wright DG, Malawista SE: Mobilization and extracellular release of granular enzymes from human leukocytes during phagocytosis: inhibition by colchicine and cortisol but not by salicylates. Arthritis Rheum 1973, 16:749\u2013758.","journal-title":"Arthritis Rheum"},{"key":"73_CR36","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI116759","volume":"92","author":"CJ Roberge","year":"1993","unstructured":"Roberge CJ, Gaudry M, De Medicis R, et al.: Crystal-induced neutrophil activation: IV, specific inhibition of tyrosine phosphorylation by colchicine. J Clin Invest 1993, 92:1722\u20131729.","journal-title":"J Clin Invest"},{"key":"73_CR37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/jlb.59.6.864","volume":"59","author":"CJ Roberge","year":"1996","unstructured":"Roberge CJ, Gaudry M, Gilbert C, et al.: Paradoxical effects of colchicines on the activation of human neutrophils by chemotactic factors and inflammatory micricrystals. J Leukoc Biol 1996, 59:864\u2013871.","journal-title":"J Leukoc Biol"},{"key":"73_CR38","first-page":"L1004","volume":"271","author":"M Peters-Golden","year":"1996","unstructured":"Peters-Golden M, McNish RW, Davis JA, et al.: Colchicine inhibits arachidonate release and 5-lipoxygenase action in alveolar macrophages. Am J Physiol 1996, 271:L1004-L1013.","journal-title":"Am J Physiol"},{"key":"73_CR39","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0008-8749(89)90201-3","volume":"120","author":"YA Mekori","year":"1989","unstructured":"Mekori YA, Baram D, Goldberg A, Klajman A: Inhibition of delayed hypersensitivity reactions in mice by colchicine. Cell Immunol 1989, 120:330\u2013340.","journal-title":"Cell Immunol"},{"key":"73_CR40","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1172\/JCI107118","volume":"51","author":"E Gillespie","year":"1972","unstructured":"Gillespie E, Lichtenstein LM: Histamine release from human leukocytes: studies with deuterium oxide, colchicine and cytochalasine B. J Clin Invest 1972, 51:2941\u20132947.","journal-title":"J Clin Invest"},{"key":"73_CR41","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1749-6632.1975.tb19234.x","volume":"253","author":"WJ Malaisse","year":"1975","unstructured":"Malaisse WJ, Malaisse-Lagae F, Van Obbergen E, et al.: Role of microtubules in the phasic pattern of insulin release. Ann NY Acad Sci 1975, 253:630\u2013652.","journal-title":"Ann NY Acad Sci"},{"key":"73_CR42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1172\/JCI108078","volume":"56","author":"EP Reaven","year":"1975","unstructured":"Reaven EP, Reaven GM: A quantitative ultrastructural study of microtubule content and secretory granule accumulation in parathyroid glands of phosphate and colchicine treated rats. J Clin Invest 1975, 56:49\u201355.","journal-title":"J Clin Invest"},{"key":"73_CR43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/excr.1995.1147","volume":"218","author":"E Bonfoco","year":"1995","unstructured":"Bonfoco E, Ceccatelli S, Manzo L, Nicotera P: Colchicine induces apoptosis in cerebellar granule cells. Exp Cell Res 1995, 218:189\u2013200.","journal-title":"Exp Cell Res"},{"key":"73_CR44","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199602153340707","volume":"334","author":"BT Emmerson","year":"1996","unstructured":"Emmerson BT: The management of gout. N Engl J Med 1996, 334:445\u2013451.","journal-title":"N Engl J Med"},{"key":"73_CR45","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","volume":"17","author":"MJ Ahern","year":"1987","unstructured":"Ahern MJ, Reid C, Gordon TP, et al.: Does colchicine work? The results of the first controlled study in acute gout. Aust NZ J Med 1987, 17:301\u2013304.","journal-title":"Aust NZ J Med"},{"key":"73_CR46","first-page":"495","volume":"15","author":"SL Wallace","year":"1988","unstructured":"Wallace SL, Singer JZ: Review: systemic toxicity associated with the intravenous administration of colchicine-guidelines for use. J Rheumatol 1988, 15:495\u2013499.","journal-title":"J Rheumatol"},{"key":"73_CR47","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1001\/jama.1987.03390140090033","volume":"257","author":"WN Roberts","year":"1987","unstructured":"Roberts WN, Liang MH, Stern SH: Colchicine in acute gout: reassessment of risks and benefits. JAMA 1987, 257:1920\u20131922.","journal-title":"JAMA"},{"key":"73_CR48","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.1780170517","volume":"17","author":"HE Paulus","year":"1974","unstructured":"Paulus HE, Schlosstein LH, Godfrey RG, et al.: Prophylactic colchicine therapy of intercritical gout: a placebo-controlled study of probenecid-treated patients. Arthritis Rheum 1974, 17:609\u2013614.","journal-title":"Arthritis Rheum"},{"key":"73_CR49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0049-0172(98)80028-0","volume":"28","author":"E Ben-Chetrit","year":"1998","unstructured":"Ben-Chetrit E, Levy M: Colchicine: 1998 update. Semin Arthritis Rheum 1998, 28:48\u201359. An update on the use of colchicine in familial Mediterranean fever, with detailed description of the drug\u2019s side effects.","journal-title":"Semin Arthritis Rheum"},{"key":"73_CR50","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1056\/NEJM199503093321004","volume":"332","author":"FJ Baud","year":"1995","unstructured":"Baud FJ, Sabouraud A, Vicaut E, et al.: Brief report: treatment of severe colchicine overdose with colchicine-specific Fab fragment. N Engl J Med 1995, 332:642\u2013645.","journal-title":"N Engl J Med"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-002-0073-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-002-0073-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-002-0073-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:23:35Z","timestamp":1683865415000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-002-0073-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,5]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,5]]}},"alternative-id":["73"],"URL":"https:\/\/doi.org\/10.1007\/s11926-002-0073-2","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,5]]}}}